Effect of Belimumab on Antibody Titers in Primary APS Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The purpose of this study is to evaluate the regulatory effect of Belimumab on the antiphospholipid antibody (aPL) as well as to observe related past and new clinical events in primary antiphospholipid syndrome patients.
Epistemonikos ID: 991d4cfe284032f7218332da88f07dd07e4dd42d
First added on: Jan 01, 2025